Want to see JP:4531 full AI Analyst Report?
Top Page
Yuki Gosei Kogyo Co., Ltd.
(4531)
Select Model
Select Model
Rating:59Neutral
Price Target:
¥374.00
▲(17.98% Upside)
Action:Reiterated
Date:09/24/26
The score is driven mainly by moderate financial fundamentals: earlier improvements are tempered by the 2026 earnings decline and historically inconsistent free cash flow (despite a strong rebound in 2026). Technicals are neutral-to-soft with a negative MACD and price below the 200-day average. Valuation is reasonable with a mid-range P/E and a supportive dividend yield, but not compelling enough to lift the overall rating materially.
Positive Factors
Solid Equity Base
A consistently stronger equity base than total debt provides a meaningful financial cushion and reduces dependence on creditors. This supports resilience through weaker periods, preserves borrowing capacity for strategic needs, and gives the company greater flexibility in managing investment and shareholder returns.
Negative Factors
2026 Earnings Contraction
The steep decline in net income represents a material deterioration in earnings power and raises questions about the sustainability of earlier profitability gains. Continued margin pressure or elevated costs could reduce funds available for investment, debt reduction, and shareholder returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Solid Equity Base
A consistently stronger equity base than total debt provides a meaningful financial cushion and reduces dependence on creditors. This supports resilience through weaker periods, preserves borrowing capacity for strategic needs, and gives the company greater flexibility in managing investment and shareholder returns.
Read all positive factors
Yuki Gosei Kogyo Co., Ltd. (4531) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥7.81B
Dividend Yield2.79%
Average Volume (3M)35.25K
Price to Earnings (P/E)18.6
Beta (1Y)1.26
Revenue Growth-0.78%
EPS Growth-41.25%
CountryJP
Employees296
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)19.30
Shares Outstanding21,974,000
10 Day Avg. Volume27,930
30 Day Avg. Volume35,246
Financial Highlights & Ratios
PEG Ratio-0.41
Price to Book (P/B)0.62
Price to Sales (P/S)0.55
P/FCF Ratio4.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Yuki Gosei Kogyo Co., Ltd. Business Overview & Revenue Model
Company Description
Yuki Gosei Kogyo Co., Ltd. is a Japanese enterprise that globally researches, develops, produces, and markets sophisticated fine chemical products. Their diverse portfolio encompasses food-grade additives, pharmaceutical components, and chemicals ...
Yuki Gosei Kogyo Co., Ltd. Financial Statement Overview
Summary
Income Statement
61
Positive
Balance Sheet
68
Positive
Cash Flow
54
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.74B | 15.45B | 15.13B | 12.93B | 12.84B | 12.36B |
| Gross Profit | 2.49B | 2.55B | 3.23B | 3.26B | 3.05B | 2.36B |
| EBITDA | 1.46B | 1.62B | 2.23B | 1.93B | 1.56B | 1.18B |
| Net Income | 417.00M | 313.00M | 896.00M | 776.00M | 556.00M | 248.00M |
Balance Sheet | ||||||
| Total Assets | 25.79B | 25.73B | 27.29B | 24.75B | 22.35B | 21.38B |
| Cash, Cash Equivalents and Short-Term Investments | 1.39B | 885.00M | 973.00M | 588.00M | 1.14B | 1.86B |
| Total Debt | 6.36B | 6.71B | 8.51B | 6.87B | 5.58B | 5.54B |
| Total Liabilities | 12.41B | 12.24B | 14.18B | 12.31B | 10.87B | 10.38B |
| Stockholders Equity | 13.38B | 13.49B | 13.11B | 12.43B | 11.48B | 11.00B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.72B | -1.20B | -1.37B | -490.00M | 1.40B |
| Operating Cash Flow | 0.00 | 2.84B | 2.14B | 388.00M | 668.00M | 1.79B |
| Investing Cash Flow | 0.00 | -1.01B | -3.25B | -1.89B | -1.24B | -442.00M |
| Financing Cash Flow | 0.00 | -1.92B | 1.50B | 948.00M | -158.00M | -772.00M |
Yuki Gosei Kogyo Co., Ltd. Technical Analysis
Positive
317.00
Price Trends
355.04
Positive
354.57
Positive
368.30
Negative
Market Momentum
-0.67
Positive
51.25
Neutral
55.75
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4531, the sentiment is Positive. The current price of 317 is below the 20-day moving average (MA) of 359.40, below the 50-day MA of 355.04, and below the 200-day MA of 368.30, indicating a neutral trend. The MACD of -0.67 indicates Positive momentum. The RSI at 51.25 is Neutral, neither overbought nor oversold. The STOCH value of 55.75 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4531.
Yuki Gosei Kogyo Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥9.13B | 2.69 | ― | 1.53% | 0.56% | 238.99% | |
74 Outperform | ¥210.32B | 11.38 | ― | 4.13% | -1.25% | 34.70% | |
69 Neutral | ¥15.14B | 11.68 | ― | 3.23% | -0.22% | 4.42% | |
59 Neutral | ¥7.81B | 18.60 | ― | 2.79% | -0.78% | -41.25% | |
59 Neutral | ¥15.41B | 15.79 | ― | 1.72% | 5.09% | 14.34% | |
59 Neutral | ¥76.83B | 20.93 | ― | 0.45% | 16.43% | 50.52% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
JP:4531
Yuki Gosei Kogyo Co., Ltd.
358.00
80.04
28.79%
JP:4040
NANKAI CHEMICAL COMPANY LIMITED
3,920.00
1,099.16
38.97%
JP:4041
Nippon Soda Co., Ltd.
3,870.00
519.80
15.52%
JP:4093
Toho Acetylene Co., Ltd.
433.00
83.09
23.74%
JP:4366
Daito Chemix Corporation
465.00
143.35
44.57%
JP:4970
Toyo Gosei Co., Ltd.
9,680.00
2,924.42
43.29%
Yuki Gosei Kogyo Co., Ltd. Corporate Events
Yuki Gosei Kogyo Sees Profit Rebound Despite Margin Pressure in Q1 FY2026
Jul 31, 2026
Yuki Gosei Kogyo reported non-consolidated net sales of ¥4,284 million for the three months ended June 30, 2026, up 7.2% year on year, while operating and ordinary income fell sharply, reflecting rising costs or margin pressure. Net income, h...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.